ecancermedicalscience

Review

Role of traditional and new biomarkers in breast carcinogenesis

29 Oct 2009
D Macis, M Cazzaniga, A De Censi, B Bonanni

In recent decades, several biomarkers have been investigated as predictors of breast cancer risk, development, prognosis and treatment efficacy.

The detection of biomarkers strongly associated with breast carcinogenesis has an enormous potential, especially for selecting subjects at high risk of developing breast cancer who could benefit from chemopreventive treatments.

Although the number of potential biomarkers continues to increase, a unique biomarker for breast cancer risk prediction has not been identified and it is probable that a panel of biomarkers will prove optimal. Further studies are needed to validate breast cancer biomarkers evaluation for individual risk assessment.

This review summarises the main biomarkers, which are important at different stages of breast carcinogenesis with updates from the recent literature.

Related Articles

Tooba Ali, Nasir Ali, Syed Aun Hasan, Nawazish Zehra, Laraib Khan, Maham Khan, Mariam Hina, Bilal Ahmed, Fabiha Shakeel, Ahmed Nadeem Abbasi, Bilal Mazhar Qureshi, Asim Hafiz, Maria Tariq, Sehrish Abrar
Sudarshan Govender, Tamsin K Phillips, Fiona M Walter, Sarah Day, Bothwell Guzha, Suzanne E Scott, Zvavahera M Chirenje, John E Ataguba, Nomonde Mbatani, Nazia Fakie, Jennifer Moodley
Abbas A Abdus-salam, Chiamaka G Ehiedu, Olabisi T Ojo, Atara I Ntekim, Mutiu A Jimoh, Mariam A Bashir, Daluchukwu J Obi, Abel S Anegbe
Cassio Murilo Hidalgo Filho, Mateus Marinho Nogueira Soares, Wesley Antonio Lopes de Lima, Laura Testa, Marcela Simonis Martins Ferrari, Renata Colombo Bonadio